U-Chart Analysis:ASKA Pharmaceutical Holdings Co., Ltd.:4886

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ASKA Pharmaceutical Holdings Co., Ltd. 4886 Medicals 東証プライム March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2023年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2022年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2021年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2020年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 14,505 12,103 10,514 7,294 10,982
Other Current AssetsHelp 39,254 37,454 29,418 30,032 26,847
Tangible Fixed AssetsHelp 10,796 10,936 12,675 13,539 13,573
Intangible Fixed AssetHelp 792 817 11,893 9,368 9,598
Investments and OthersHelp 21,791 18,314 12,716 15,790 15,460
Total AssetsHelp 87,138 83,297 82,582 80,239 82,194
Total Current LiabilitiesHelp 23,420 22,082 24,325 24,995 25,768
Total Long-term LiabilitiesHelp 9,185 12,323 13,747 13,671 12,970
Shareholder's EquityHelp 54,533 48,892 44,510 41,573 43,456
Total LiabilitiesHelp 87,138 83,297 82,582 80,239 82,194

ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2023年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2022年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2021年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2020年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 60,461 56,607 55,181 52,542 46,706
Total Sales 60,461 56,607 55,181 52,542 46,706
Cost of SalesHelp 31,876 30,255 29,798 28,525 27,814
Other Costs and RevenueHelp 24,346 22,062 22,669 23,368 17,147
Total CostsHelp 56,222 52,317 52,467 51,893 44,961
Net RevenueHelp 28,585 26,352 25,383 24,017 18,892
Earnings Before TaxHelp 5,357 6,163 3,575 901 1,883
Net IncomeHelp 4,239 4,290 2,714 649 1,745
Net Income 4,239 4,290 2,714 649 1,745

ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2023年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2022年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2021年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2020年3月期 ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 3,350 2,842 6,540 -493 2,504
Investing Cash Flow(ICF)Help -1,126 6,743 -2,866 -2,927 -14,780
Financing Cash FlowHelp -1,820 -2,996 -455 -392 13,036
Exchange Difference of Cash and Cash EquivalentsHelp -2 0 0 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn 402 6,589 3,219 -3,812 760

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ASKA Pharmaceutical Holdings Co., Ltd.

Company where related level is highHelp

NANO MRNA Co., Ltd.
D.Western Therapeutics Institute, Inc.
SAWAI PHARMACEUTICAL CO.,LTD.
TAISHO PHARMACEUTICAL CO.,LTD.
Kyowa Kirin Co.,Ltd.
Fuji Pharma Co.,Ltd.
Nippon Shinyaku Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
NIPPON CHEMIPHAR CO.,LTD.
DENKA SEIKEN Co.,Ltd.